Publicaciones en colaboración con investigadores/as de Hospital Universitario de Guadalajara (4)

2021

  1. Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group

    BMC Cancer, Vol. 21, Núm. 1

2007

  1. Cyclooxygenase-2 (COX-2): A molecular target in prostate cancer

    Clinical and Translational Oncology, Vol. 9, Núm. 11, pp. 694-702

  2. Prostate cancer and Hedgehog signalling pathway

    Clinical and Translational Oncology, Vol. 9, Núm. 7, pp. 420-428

  3. Prostate carcinoma and stem cells

    Clinical and Translational Oncology, Vol. 9, Núm. 2, pp. 66-76